Who Owns Abbott Medical Devices?
Abbott Medical Devices is the device business of Abbott Laboratories (NYSE: ABT), the American healthcare company headquartered in Abbott Park, Illinois. Its device portfolio spans rhythm management, electrophysiology, cardiovascular stents and structural heart products including MitraClip, and neuromodulation, while the closely related FreeStyle Libre continuous glucose monitor franchise makes Abbott the diabetes care market leader. Abbott's device and diagnostics businesses generated more than $20 billion in combined annual revenue.
Parent Company
Founded
1888
Status
Publicly Traded
Headquarters
Who Owns Abbott Medical Devices?
- Parent Company: Abbott Laboratories
- Ownership Type: Brand division
- Company Type: Publicly Traded
- Stock Ticker: NYSE: ABT
| Brand | Parent Company | Ownership Type |
|---|---|---|
| Abbott Medical Devices | Abbott Laboratories | Brand division |
Where to Buy
Disclosure: We may earn commission from purchases
Abbott Medical Devices on AmazonAdvertisement
History of Abbott Medical Devices
- Founded: 1888
- Founders: Wallace Calvin Abbott
Abbott's device operations grew from the pharmaceutical company's diversification into diagnostics and hospital products over the twentieth century. Its early device-adjacent businesses included cardiovascular stents developed from its vascular products division, producing the Xience drug-eluting stent line that became a market leader.
The transformational event was the January 2017 acquisition of St. Jude Medical for approximately $25 billion. St. Jude brought market-leading positions in cardiac rhythm management (pacemakers and implantable defibrillators), structural heart including the MitraClip mitral valve repair system, electrophysiology with the EnSite mapping platform, and neuromodulation including spinal cord stimulation.
The FreeStyle Libre continuous glucose monitoring franchise, launched in 2014, grew explosively through the late 2010s and 2020s into a multi-billion-dollar business that made Abbott the global leader in CGM against Dexcom. By 2024-2025, Libre franchise sales alone exceeded $6 billion annually.
Through 2024-2026, Abbott continued expanding its device business with new Libre generations, structural heart pipeline products, and neuromodulation expansion including its Eterna rechargeable spinal cord stimulator and Proclaim deep brain stimulation systems.
Advertisement
About Abbott Laboratories
What does Abbott Laboratories own?
Abbott Laboratories owns brands across nutrition (Similac, Ensure, PediaSure, Pedialyte), medical devices (FreeStyle Libre, Volt, TactiFlex, Amulet), and diagnostics (Cologuard, BinaxNOW, Alinity). The company acquired Exact Sciences in March 2026 for $21 billion, adding Cologuard and other molecular diagnostic products.
Is Abbott Laboratories publicly traded?
Yes, Abbott Laboratories trades on the New York Stock Exchange under the ticker symbol ABT. The company has been publicly listed since 1929 and is a component of the S&P 500 Index.
Who founded Abbott Laboratories?
Abbott was founded in 1888 by Dr. Wallace Calvin Abbott, a physician in Ravenswood, Illinois (now part of Chicago). He began by manufacturing reliable dosimetric granules for pharmaceutical use.
Where is Abbott Laboratories headquartered?
Abbott is headquartered in Abbott Park, North Chicago, Illinois, USA. The company operates in more than 160 countries globally.
Advertisement
How many brands does Abbott Laboratories own?
Abbott owns numerous brands across its four segments. Key consumer brands include Similac, Ensure, PediaSure, and Pedialyte in nutrition. Key medical device brands include FreeStyle Libre, Volt, and Amulet. Key diagnostics brands include Cologuard, BinaxNOW, and Alinity.
Who owns Abbott Laboratories?
Abbott Laboratories is a publicly traded company with shares held by institutional investors, mutual funds, and individual shareholders. The company is led by Chairman and CEO Robert B. Ford.
What is Abbott Laboratories' revenue?
Abbott reported Q2 2026 sales of $12.59 billion, up 13.0% on a reported basis and 4.8% on a comparable basis. The company reaffirmed full-year 2026 comparable sales growth guidance of 6.5% to 7.5% and raised adjusted diluted EPS guidance to $5.45 to $5.60.
Did Abbott acquire Exact Sciences?
Yes, Abbott completed the $21 billion acquisition of Exact Sciences in March 2026. The acquisition added Cologuard, a noninvasive colorectal cancer screening test, to Abbott's diagnostics portfolio. Diagnostics sales grew 42% year over year in Q2 2026, the first full quarter including Exact Sciences results.
Advertisement
- Founded: 1888
- Headquarters: North Chicago, Illinois, USA
- Company Type: Publicly Traded
- Stock: NYSE: ABT
- Revenue: $12.6B Q2 2026 (annualized ~$50B)
- Employees: ~114,000
Where Is Abbott Medical Devices Made / Based?
- Headquarters: Abbott Park, Illinois, USA
- Manufacturing / Operations: United States, Ireland, Costa Rica, Singapore, China
Abbott Medical Devices Categories & Tags
Abbott Medical Devices Recalls & Controversies
Abbott's device business carries the routine FDA recall history of a large cardiovascular manufacturer, including periodic field corrections for implantable defibrillators, pacemakers, and Libre sensors over the years.
The company faced scrutiny in the early 2020s over FreeStyle Libre accuracy claims in certain edge cases and marketing practices, resolved through label updates and routine FDA interactions rather than major enforcement action. Its structural heart and neuromodulation products carry standard device-industry clinical safety review.
Broader Abbott controversies, including the 2022 infant formula plant shutdown crisis, relate to its Nutrition segment rather than devices and do not directly affect the medical device business.
Advertisement
Brands Owned by Abbott Laboratories
Baby CareEleCare
Owned by Abbott Laboratories
Amino acid-based hypoallergenic infant and child formula brand owned by Abbott Laboratories, launched in 2003 for severe protein allergies and manufactured at Abbott's Sturgis, Michigan facility.
infant-formulahypoallergenicamino-acid-formula
Healthcare PharmaceuticalsEnsure
Owned by Abbott Laboratories
American adult nutrition shake brand owned by Abbott Laboratories, introduced in 1973 and sold in more than 160 countries as a complete nutritional supplement.
adult-nutritionnutritional-supplementabbott
Healthcare PharmaceuticalsPedialyte
Owned by Abbott Laboratories
Oral electrolyte solution brand owned by Abbott Laboratories, first issued to hospitals in 1966 and now marketed to children and adults for hydration.
electrolyte-drinkrehydrationabbott
Baby CarePediaSure
Owned by Abbott Laboratories
Children's nutritional supplement drink brand owned by Abbott Laboratories, launched in 1988 and marketed for children ages 1 to 13 needing supplemental nutrition.
child-nutritionnutritional-supplementabbott
Baby CareSimilac
Owned by Abbott Laboratories
American infant formula brand owned by Abbott Laboratories, introduced in 1925 and the largest infant formula brand in the United States. Similac faced a major product recall in 2022 that contributed to a national infant formula shortage.
infant-formulababy-nutritionbaby-care
Abbott Medical Devices Ownership: Pros & Cons
Advantages
- +Abbott's financial strength funds sustained device R&D across four segments
- +FreeStyle Libre dominates the highest-growth device category, CGM
- +St. Jude acquisition built top-tier cardiovascular and neuromodulation franchises
- +Structural heart leadership through MitraClip is difficult to replicate
- +160-plus country distribution provides unmatched device reach
Considerations
- -Device business is one of four segments, splitting corporate investment priority
- -CGM competition from Dexcom is intensifying
- -No orthopaedic presence limits exposure to that device category
- -Rhythm management faces Medtronic and Boston Scientific scale competition
- -Diabetes care reimbursement dynamics create pricing pressure
Advertisement
Frequently Asked Questions About Abbott Medical Devices
Sources & Further Reading
Advertisement
Competitors to Abbott Medical Devices
No direct competitors found in the same category. This could be because Abbott Medical Devicesoperates in a unique market segment or we're still building our competitor database.
Advertisement
Independent Alternatives to Abbott Medical Devices
Looking for brands with different ownership structures? These similar brands are not owned by Abbott Laboratories, giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsVoraxaze
Owned by SERB Pharmaceuticals
Glucarpidase rescue therapy for toxic methotrexate levels, owned by SERB Pharmaceuticals since its 2021 acquisition of BTG.
oncologyglucarpidasemethotrexate-rescue
Privately Owned
Voraxaze is privately owned, unlike Abbott Medical Devices which is under a publicly traded parent company.
Healthcare PharmaceuticalsPhilips
Owned by Koninklijke Philips N.V.
Health technology brand owned by Koninklijke Philips N.V., a publicly traded Dutch company listed on Euronext Amsterdam (PHIA). Covers medical imaging, patient monitoring, and personal health products.
healthcare-technologyelectronicsmedical-devices
Publicly Traded
Philips operates independently without a large parent corporation.
Healthcare PharmaceuticalsSmith+Nephew
Owned by Smith+Nephew plc
British medical technology company founded in 1856, reporting $6.16 billion in FY2025 revenue across orthopaedics, sports medicine, and advanced wound management, listed on the London Stock Exchange.
medical-devicesorthopedicswound-care
Publicly Traded
Smith+Nephew operates independently without a large parent corporation.
Healthcare PharmaceuticalsZimmer Biomet
Owned by Zimmer Biomet Holdings, Inc.
Zimmer Biomet is the flagship orthopedic brand of Zimmer Biomet Holdings, producing knee, hip, and trauma implants plus the ROSA surgical robotics platform from its Warsaw, Indiana base.
orthopedicsmedical-devicesimplants
Publicly Traded
Zimmer Biomet operates independently without a large parent corporation.
Healthcare PharmaceuticalsBoehringer Ingelheim
Owned by Boehringer Ingelheim
German family-owned pharmaceutical brand behind Jardiance and Spiriva, founded in 1885 and still controlled by the Boehringer family.
pharmaceuticalsprescription-drugsanimal-health
Privately Owned
Boehringer Ingelheim is privately owned, unlike Abbott Medical Devices which is under a publicly traded parent company.
Healthcare PharmaceuticalsBrainlab
Owned by Brainlab SE
Munich surgical navigation and radiotherapy software brand installed in about 4,000 hospitals worldwide.
medical-technologysurgical-navigationradiosurgery
Privately Owned
Brainlab is privately owned, unlike Abbott Medical Devices which is under a publicly traded parent company.
Abbott Laboratories Stock Information
Advertisement
Jobs at Abbott Laboratories
Latest News About Abbott Medical Devices
Advertisement
Related Articles About Abbott Medical Devices
View more articles
Industry Ownership
Who Owns the Baby Formula Market
Abbott, Reckitt, and Nestlé control most of the baby formula sold in the United States and globally. Here is a complete breakdown of who owns the baby formula market, the major brands, and how a supply chain crisis exposed the dangers of concentration.
Who Brands StaffMar 21, 2026
Baby FormulaIndustry OwnershipAbbott
News & Updates
Monthly M&A Roundup: October 2026 Brand Ownership Changes
October 2026's biggest deals: Paramount Skydance closed its $110B Warner Bros. Discovery takeover, Salesforce signed Braze for $5.66B, Proofpoint bought Varonis for $6.3B, the Weston family agreed to buy Boots for $8.9B, and Viatris added Pacira for $1.65B. Full breakdown.
Who Brands StaffNov 6, 2026
M And A RoundupAcquisitionsNews
Health
Dental Brand Ownership Beyond Colgate and Crest
Colgate holds 41.3% global toothpaste share. P&G (Crest, Oral-B) has 14.1%. Haleon (Sensodyne) has 4.4%. Church & Dwight is the only independent at scale. The oral care market is $47.2B. Explore our database.
Who Brands StaffNov 12, 2026
ColgateCrestOral B
People Also Searched
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.
Brandpharmaceutical
Abbokinase
Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.
Brand in Healthcare & Pharmaceuticals
thrombolyticurokinase
Brandrsv-vaccine
Abrysvo
Pfizer's respiratory syncytial virus (RSV) vaccine approved for older adults, maternal immunization to protect infants, and younger at-risk adults. Launched 2023.
Brand in Healthcare & Pharmaceuticals
vaccinesmaternal-immunization
Brandspecialty-pharmacy
Accredo
Specialty pharmacy founded in 1996 in Memphis, serving patients with complex and rare conditions as the specialty pharmacy of Evernorth within The Cigna Group.
Brand in Healthcare & Pharmaceuticals
rare-diseaseevernorth